Crystalline Management’s Xeris Biopharma Holdings XERS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-16,573
Closed -$36.6K 97
2024
Q1
$36.6K Buy
+16,573
New +$36.6K 0.05% 55